食物与制剂对DRL-17822在健康男性中群体药代动力学的影响
该研究基于4项I期试验,在健康男性中表征胆固醇酯转移蛋白抑制剂DRL-17822的群体药代动力学,并探讨食物和制剂对口服吸收的影响。采用二室模型加6个转运吸收室拟合数据,发现食物与制剂对生物利用度存在强交互作用,无定形固体分散体制剂的食物效应低于纳米晶制剂。
要点
- 食物与制剂对DRL-17822生物利用度存在强交互作用。
- 无定形固体分散体制剂的食物效应低于纳米晶制剂。
- 最终模型可充分表征健康男性中DRL-17822的复杂药代动力学。
核心结论
- 食物与制剂对DRL-17822口服生物利用度存在强交互作用,无定形固体分散体制剂的食物效应低于纳米晶制剂。
研究设计与样本
- 基于4项I期研究,健康男性口服DRL-17822 2-1000 mg,涉及两种制剂(纳米晶和无定形固体分散体)及不同餐食状态。
- 采用二室模型加6个转运吸收室的群体药代动力学建模方法。
主要发现
- 最终模型充分表征了健康男性中DRL-17822的药代动力学数据,包括食物与制剂间的复杂交互作用。
- 通过将食物状态与制剂的组合按相似生物利用度分箱,简洁地表征了食物与制剂的强交互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to characterise the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy males and explore the effect of food and formulation on the oral absorption of DRL-17822 in 4 phase I studies. DRL-17822 was dosed orally (2-1000 mg) in 2 different drug formulations (nanocrystal formulation and amorphous solid dispersion formulation) after either an overnight fast, or a low-fat, continental or high-fat breakfast. A 2-compartment model with 6 transit absorption compartments best characterised the data. Additionally, a strong interaction of food and formulation on bioavailability was observed and parsimoniously characterised in the model by binning combinations of food state and formulation with similar bio-availabilities. The final model adequately characterised the pharmacokinetic data of DRL-17822 in healthy males including the complex interaction of food and drug formulation. The amorphous solid dispersion formulation has a lower food effect on bioavailability compared with the nanocrystal formulation.
引用
- Goulooze SC, Kruithof AC, Alikunju S, et al. The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers. Br J Clin Pharmacol. 2020. PMID: 32250455. doi:10.1111/bcp.14297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。